Tandem Diabetes (TNDM) Technical (Analysis) Reports Tandem Diabetes ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Tandem Diabetes (TNDM)
Technical Analysis Report for USA stock TNDM Tandem Diabetes. Dated: 14 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Medical Dental Instruments in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock TNDM Tandem Diabetes then click here. or read Experts views on Tandem Diabetes or Forecast & share price targets of Tandem Diabetes
Tandem Diabetes Opened at 17.18 and Closed at: 16.81, which is -1.78% of previous session's close. It moved within a range of 16.60 and 17.62
The session was a Bearish session with an average volume of 2201400, which is 18.73% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Dead cross was found 9 days back on short term averages
Support for tomorrow is 16.2 and resistance for tomorrow is 17.22
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 16.4, 15.99 resistance for tomorrow's hourly charts is 17.42, 18.03
10 Day SMA for Tandem Diabetes (TNDM) is 19.54 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Tandem Diabetes (TNDM) is 20.89 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Tandem Diabetes (TNDM) is 19.44 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 18.01 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Tandem Diabetes is 19.67 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Tandem Diabetes is at 20.89 and 200 DMA is at 19.67, while 50 DMA and 100 DMA are at 19.44 and 18.01 respectively
Tandem Diabetes (TNDM) moving average of 20 SMA is at 20.89 and 20 EMA is at 19.95
| Date | Closing Price | 20 SMA | 20 EMA |
| 14 Mon Sep | 16.81 | 20.89 | 19.95 |
| 11 Fri Sep | 17.11 | 21.18 | 20.28 |
| 10 Thu Sep | 18.31 | 21.49 | 20.61 |
| 09 Wed Sep | 19.11 | 21.74 | 20.85 |
| 08 Tue Sep | 19.88 | 21.96 | 21.03 |
| 04 Fri Sep | 19.90 | 22.1 | 21.15 |
Tandem Diabetes (TNDM) moving average of 50 SMA is at 19.44 and 50 EMA is at 19.65
| Date | Closing Price | 50 SMA | 50 EMA |
| 14 Mon Sep | 16.81 | 19.44 | 19.65 |
| 11 Fri Sep | 17.11 | 19.41 | 19.77 |
| 10 Thu Sep | 18.31 | 19.38 | 19.88 |
| 09 Wed Sep | 19.11 | 19.32 | 19.94 |
| 08 Tue Sep | 19.88 | 19.24 | 19.97 |
| 04 Fri Sep | 19.90 | 19.16 | 19.97 |
Tandem Diabetes (TNDM) moving average of 100 SMA is at 18.01 and 100 EMA is at 19.13
| Date | Closing Price | 100 SMA | 100 EMA |
| 14 Mon Sep | 16.81 | 18.01 | 19.13 |
| 11 Fri Sep | 17.11 | 18.05 | 19.18 |
| 10 Thu Sep | 18.31 | 18.08 | 19.22 |
| 09 Wed Sep | 19.11 | 18.1 | 19.24 |
| 08 Tue Sep | 19.88 | 18.12 | 19.24 |
| 04 Fri Sep | 19.90 | 18.13 | 19.23 |
Tandem Diabetes (TNDM) moving average of 200 SMA is at 19.67 and 200 EMA is at 19.03
| Date | Closing Price | 200 SMA | 200 EMA |
| 14 Mon Sep | 16.81 | 19.67 | 19.03 |
| 11 Fri Sep | 17.11 | 19.7 | 19.05 |
| 10 Thu Sep | 18.31 | 19.72 | 19.07 |
| 09 Wed Sep | 19.11 | 19.74 | 19.08 |
| 08 Tue Sep | 19.88 | 19.74 | 19.08 |
| 04 Fri Sep | 19.90 | 19.73 | 19.07 |
Stryker Corporation has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Stryker Corporation, about 9.46% more returns!
Merck Company has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Merck Company, about 31.02% more returns!
Hca Healthcare has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Hca Healthcare, about 29.53% more returns!
Boston Scientific has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Boston Scientific, about 12.06% more returns!
Zymeworks Inc has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Zymeworks Inc, about 30.56% more returns!
Veracyte Inc has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Veracyte Inc, about 22.41% more returns!
Sellas Life has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Sellas Life, about 14.78% more returns!
Si Bone has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Si Bone, about 24.53% more returns!
Pulse Biosciences has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Pulse Biosciences, about 40.34% more returns!
Ocular Therapeutix has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Ocular Therapeutix, about 25.14% more returns!
Moderna Inc has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Moderna Inc, about 152.17% more returns!
Genprex Inc has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Genprex Inc, about 1.66% more returns!
Ensign Group has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Ensign Group, about 20.84% more returns!
Cytomx Therapeutics has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Cytomx Therapeutics, about 17.23% more returns!
Celldex Therapeutics has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 17.94% more returns!
Tandem Diabetes has performed better than Chemocentryx Inc in short term. Holding Tandem Diabetes could be a better choice for now!
Atricure Inc has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Atricure Inc, about 49.09% more returns!
Apyx Medical has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Apyx Medical, about 23.17% more returns!
Acadia Healthcare has performed better than Tandem Diabetes in short term. You could have earned much better returns by investing in Acadia Healthcare, about 17.81% more returns!
Tandem Diabetes Technical analysis of indicators
Price action analysis of Tandem Diabetes (TNDM) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Tandem Diabetes stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Tandem Diabetes in short term and the sell signal is strong.
Tandem Diabetes Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Tandem Diabetes in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Tandem Diabetes is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 19.3 and Tandem Diabetes TNDM stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Tandem Diabetes TNDM stock. Volume based technical analysis of Tandem Diabetes TNDM stock is negative.
Tandem Diabetes Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock TNDM Tandem Diabetes These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And TNDM Experts View which covers a lot of information including buying and selling signals
TNDM future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Tandem Diabetes or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Tandem Diabetes (TNDM) Technical (Analysis) Reports Tandem Diabetes ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


